Search research articles
Contact Us
Filters
Showing results (621-630 of 709) with videos related to
Page
of 71
Sort By:
Scientific Reports
|
August 28, 2023
Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury
Takayuki Kondo, Kentaro Fujimoto, Kisako Fujiwara, et al.
Oncology Letters
|
August 13, 2020
Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
Yushi Imai, Tetsuhiro Chiba, Takayuki Kondo, et al.
Molecular Cancer Therapeutics
|
October 3, 2018
Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer
Yu Sunakawa, Kaoru Mogushi, Heinz-Josef Lenz, et al.
Circulation. Cardiovascular Interventions
|
March 16, 2019
Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical Presentation
Tullio Palmerini, Antonio G Bruno, Martine Gilard, et al.
Heart and Vessels
|
January 1, 2022
Relationship between platelet aggregation and stroke risk after percutaneous coronary intervention: a PENDULUM analysis
Yuji Matsumaru, Takanari Kitazono, Kazushige Kadota, et al.
Biochemical Pharmacology
|
February 27, 2025
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma
Na Qiang, Junjie Ao, Masato Nakamura, et al.
Cancer Biology & Therapy
|
April 23, 2016
Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer
Yu Sunakawa, Dongyun Yang, Miriana Moran, et al.
Cancer Science
|
February 6, 2021
Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer
Shin Takahashi, Yasuhiro Sakamoto, Tadamichi Denda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinoma
Takuya Yonemoto, Sadahisa Ogasawara, Naoya Kanogawa, et al.
International Journal of Cardiology
|
March 21, 2025
Cumulative plaque burden analysis for phenotyping epicardial coronary artery disease
Tsung-Ying Tsai, Pruthvi C Revaiah, Ali Aldujeli, et al.
Page
of 71
Search research articles
Search
Showing results (621-630 of 709) with videos related to
Sort By:
Page
of 71
Scientific Reports
|
August 28, 2023
Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury
Takayuki Kondo, Kentaro Fujimoto, Kisako Fujiwara, et al.
Oncology Letters
|
August 13, 2020
Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
Yushi Imai, Tetsuhiro Chiba, Takayuki Kondo, et al.
Molecular Cancer Therapeutics
|
October 3, 2018
Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer
Yu Sunakawa, Kaoru Mogushi, Heinz-Josef Lenz, et al.
Circulation. Cardiovascular Interventions
|
March 16, 2019
Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical Presentation
Tullio Palmerini, Antonio G Bruno, Martine Gilard, et al.
Heart and Vessels
|
January 1, 2022
Relationship between platelet aggregation and stroke risk after percutaneous coronary intervention: a PENDULUM analysis
Yuji Matsumaru, Takanari Kitazono, Kazushige Kadota, et al.
Biochemical Pharmacology
|
February 27, 2025
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma
Na Qiang, Junjie Ao, Masato Nakamura, et al.
Cancer Biology & Therapy
|
April 23, 2016
Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer
Yu Sunakawa, Dongyun Yang, Miriana Moran, et al.
Cancer Science
|
February 6, 2021
Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer
Shin Takahashi, Yasuhiro Sakamoto, Tadamichi Denda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinoma
Takuya Yonemoto, Sadahisa Ogasawara, Naoya Kanogawa, et al.
International Journal of Cardiology
|
March 21, 2025
Cumulative plaque burden analysis for phenotyping epicardial coronary artery disease
Tsung-Ying Tsai, Pruthvi C Revaiah, Ali Aldujeli, et al.
Page
of 71